RUCAPARIB for Small cell lung cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 29 adverse event reports in the FDA FAERS database where RUCAPARIB was used for Small cell lung cancer.
Most Reported Side Effects for RUCAPARIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Anaemia | 49 | 11.3% | 2 | 37 |
| Acute kidney injury | 34 | 7.8% | 6 | 34 |
| Febrile neutropenia | 33 | 7.6% | 2 | 33 |
| Fatigue | 32 | 7.4% | 1 | 10 |
| Nausea | 30 | 6.9% | 0 | 15 |
| Pancytopenia | 27 | 6.2% | 2 | 24 |
| Diarrhoea | 23 | 5.3% | 1 | 18 |
| Drug ineffective | 22 | 5.1% | 6 | 1 |
| Vomiting | 20 | 4.6% | 0 | 16 |
| Abdominal pain | 17 | 3.9% | 0 | 15 |
| Thrombocytopenia | 17 | 3.9% | 4 | 12 |
| Constipation | 15 | 3.5% | 0 | 5 |
| Malignant neoplasm progression | 15 | 3.5% | 8 | 6 |
| Pyrexia | 13 | 3.0% | 0 | 11 |
| Decreased appetite | 12 | 2.8% | 0 | 3 |
Other Indications for RUCAPARIB
Ovarian cancer (201)
Prostate cancer metastatic (34)
Hormone-refractory prostate cancer (27)
Prostate cancer (27)
Endometrial cancer (15)
Neoplasm (13)
Product used for unknown indication (12)
Fallopian tube cancer (9)
Neoplasm malignant (9)
Malignant peritoneal neoplasm (7)
Other Drugs Used for Small cell lung cancer
ETOPOSIDE (2,514)
ATEZOLIZUMAB (2,107)
CARBOPLATIN (1,991)
DURVALUMAB (1,063)
CISPLATIN (787)
NIVOLUMAB (787)
IPILIMUMAB (474)
LURBINECTEDIN (351)
TARLATAMAB-DLLE (332)
IRINOTECAN (329)